Gline Matthew Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$27.82M

Insider Activity of Gline Matthew

According to the SEC Form 4 filings, Gline Matthew, being in a position of

  1. CEO at Roivant Sciences Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 2029774 shares for $46.17M,
    over all time since 2022-03-07, has bought 3315 shares for $49,957, and sold 4997731 share for $74M.

Biography of Gline Matthew

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$46,173,0102100

Comparison of Insiders on Amount of Buys and Sells

2026-04-16SaleRoivant Sciences Ltd.
ROIV
CEO
289,774
0.0404%
$29.16$8.45M+18.67%
2025-12-15SaleRoivant Sciences Ltd.
ROIV
CEO
1.74M
0.2478%
$21.68$37.72M+35.07%
2025-09-18PurchaseRoivant Sciences Ltd.
ROIV
CEO
3,315
0.0005%
$15.07$49,957+85.09%
2024-09-23SaleRoivant Sciences Ltd.
ROIV
CEO
1.98M
0.2657%
$11.79$23.38M-4.45%
2022-10-25SaleRoivant Sciences Ltd.
ROIV
CEO
38,552
0.005%
$4.40$169,629+85.56%
2022-09-23SaleRoivant Sciences Ltd.
ROIV
CEO
42,106
0.0062%
$3.07$129,265+185.95%
2022-08-24SaleRoivant Sciences Ltd.
ROIV
CEO
40,018
0.0056%
$3.71$148,467+112.89%
2022-07-25SaleRoivant Sciences Ltd.
ROIV
CEO
40,910
0.0061%
$4.33$177,140+82.45%
2022-06-23SaleRoivant Sciences Ltd.
ROIV
CEO
39,710
0.0053%
$4.34$172,341+52.15%
2022-05-20SaleRoivant Sciences Ltd.
ROIV
CEO
279,582
0.0402%
$3.70$1.03M+42.16%
2022-04-25SaleRoivant Sciences Ltd.
ROIV
CEO
17,018
0.0023%
$3.84$65,349+19.01%
2022-03-30SaleRoivant Sciences Ltd.
ROIV
CEO
67,372
0.0099%
$4.84$326,080-5.27%
2022-03-25SaleRoivant Sciences Ltd.
ROIV
CEO
70,772
0.0104%
$5.06$358,106-9.84%
2022-03-18SaleRoivant Sciences Ltd.
ROIV
CEO
164,012
0.0234%
$5.13$841,382-13.49%
2022-03-07SaleRoivant Sciences Ltd.
ROIV
CEO
184,648
0.0274%
$5.52$1.02M-16.54%
Total: 15
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.